6
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Pre- and Postoperative DNA Ploidy Patterns Correlated to Pt-Stage, Histological Grade and Tumour Volume in Total Prostatectomy Specimens

, , , , &
Pages 59-66 | Received 15 Feb 1993, Accepted 25 May 1993, Published online: 15 Feb 2010

REFERENCES

  • Adolfson J, Rönström L, Hedlund PO, Lövhagen T, Carstensen J, Tribukait B. The prognostic value of modal Deoxyribonucleic acid in low grade, low stage untreated prostatic cancer. J Urol 1990; 144: 1404–1407.
  • Adolfson J, Carstensen J, Löwhagen T. Deferred treatment in clinically localized prostatic carcinomas. Br J Urol 1992; 69: 183–187.
  • Blute ML, Nativ O, Zincke H, Farrow GM, Therneau T, Lieber M. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: Influence of tumour DNA ploidy. J Urol 1989; 142: 1262–1265.
  • Bostwick DG, Brawer MK. Prostatic intra-epithelial neoplasia and early invasion on prostata cancer. Cancer 1987; 59: 788–794.
  • Brawer MK. Prostatic intraepithelial neoplasia: A premalignant lesion. Human Pathol 1992; 23: 242–248.
  • Byar DP, Mostofi FK. Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Cancer 1972; 30: 5–132.
  • Epstein JI. The evaluation of radical prostatectomy specimens. Therapeutic and prognostic implication. Path Ann 1990; Part 7: 26: 159–210, Appleton & Lange.
  • Falkmer U. Methodologic sources of errors in image and flow cytometric DNA assessments of the malignant potential of prostatic carcinoma. Human Pathol 1992; 23: 360–367.
  • Forsslund G, Zetterberg A. Ploidy level determinations in high grade and low grade malignant variants of prostatic carcinoma. Cancer Res 1990; 50: 4281–4285.
  • Forsslund G, Esposti P-L, Nilsson B, Zetterberg A. The prognostic significance of nuclear DNA content in prostatic carcinoma. Cancer 1992; 69: 1432–1439.
  • Frankfurt OS, Chin JL, Englander LS, Greco WR, Pontes JE, Rustum YM. Relationship between DNA ploidy, glandular differentiation and tumour spread in human prostate cancer. Cancer Res 1985; 45: 1418–1423.
  • Gleason DF, Mellinger GT, The VACURG. Prediction of prognosis for prostatic adenocarcinoma combining histological grading and clinical staging. J Urol 1974; 111: 58–64.
  • Greene DR, Taylor SR, Wheeler TM, Scardino PT. DNA ploidy by image analysis of individual foci of prostate cancer. Preliminary report. Cancer Res 1991; 51: 4084–4089.
  • Häggman M, Norberg M, de la Torre M, Fritiofsson Å, Busch C. Characterization of localized prostatic cancer: Distribution, grading and pT-staging in radical prostatectomy specimens. Scand J Urol Nephrol 1993; 27: 7–13.
  • Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded material using flow cytometry. J Histochem Cytochem 1983; 31: 1333–1335.
  • Johansson JE, Adami HO, Andersson SO, Bergström R, Holmberg L, Krusemo UB. High 10-year survival rates in patients with early, untreated prostatic cancer. JAMA 1992; 267: 2191–2196.
  • Lange PH, Narayan P. Understaging and undergrading of prostate cancer. Urology 1983; 21: 113–118.
  • Lee F, Gray JM, McLeary TR et al. Transrectal ultrasound in the diagnosis of prostate cancer: Location, echogenicity, histopathology and stage. Prostate 1985; 7: 117–129.
  • Lundberg S, Carstensen J, Rundquist I. DNA flow-cytometry and histopathological grading of paraffin-embedded prostate biopsy specimens in a survival study. Cancer Res 1987; 47: 1973–1977.
  • Malmström P-U, Vasko J, Wester K, Norlén BJ, Busch C. Flow cytometric analysis of DNA content of deparaffinied nuclei in urinary bladder carcinomas. APMIS 1989; 97: 811–819.
  • McIntire TL, Murphy WM, Coon JS, Chandler RW, Schwartz D, Conway S, Weinstein RS. The prognostic value of DNA ploidy combined with histologic substaging for incidental carcinoma of the prostate gland. Am J Clin Pathol 1988; 89: 370–373.
  • Mukamel E, Hannah J, Barbaric Z and de-Kernion JB. The value of computerized tomography scan and magnetic resonance imaging in staging prostatic carcinoma: Comparison with the clinical and histological staging. J Urol 1986; 136: 1231–1233.
  • Muntzing J. DNA determinations for prognosis and therapy control in prostatic cancer. Semin Oncol 1983; 10 (suppl 3): 16–20.
  • Nativ O, Winkler HZ, Raz Y et al. Stage C prostatic adenocarcinoma: Flow cytometric nuclear DNA-ploidy analysis. Mayo Clin Proc 1989; 64: 911–919.
  • Norberg M, Häggman M, Andersson T, Busch C, Magnusson A. Evaluation of localized prostatic cancer. A comparative study of transrectal ultrasonography versus histopathology. Eur Radiol 1993; 3: 166–173.
  • Oesterling JE, Brendler CB, Epstein JI, Kimball AW, Walsh PC. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 1987; 138: 92–98.
  • Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC. Morphometric measurement of tumour volume and percent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol 1989; 141: 341–345.
  • Paulson DF, Stone AR, Walther PJ, Tucker JA, Cox EB. Radical prostatectomy: Anatomical predictors of success or failure. J Urol 1986; 136: 1041–1043.
  • van der Poel HG, Schaafsma HE, Vooijs PG, Debruyne FMJ, Shalken J. Quantitative light microscopy in urological oncology. J Urol 1992; 148: 1–13.
  • Pontes JE, Wajsman Z, Huben RP, Wolf RM, Englander LS et al. Prognostic factors in localized prostatic carcinoma. J Urol 1985; 134: 1137–1139.
  • Ritchie AWS, Dorey F, Layfield LJ, Hannah J, Lonekovich H, de Kernion JB. Relationship of DNA-content to conventional prognostic factors in clinically localized carcinoma of the prostate. Br J Urol 1988; 62: 254–260.
  • Salo JO, Rannikko S, Mäkinen J, Lehtonen T. Echogenic structure of prostatic cancer imaged on radical prostatectomy specimens. Prostate 1987; 10: 1–9.
  • Shinohara K, Wheeler T, Scardino PT. The appearance of prostate cancer on transrectal ultrasonography: Correlation of imaging and pathological examinations. J Urol 1989; 142: 76–82.
  • Stamey TA, McNeal JE, Freiha FS, Redwine E. Morphometric and clinical studies on 68 radical prostatectomies. J Urol 1988; 139: 1235–1241.
  • Stephenson RA, James BC, Gay H, Fair WR, Whitmore WF, Melamed MR. Flow cytometry of prostate cancer: Relationship of DNA content to survival. Cancer Res 1987; 47: 2504–2507.
  • de la Torre M, Häggman M, Brändstedt S, Busch C. Prostatic intraepithelial neoplasia (PIN) and invasive adenocarcinoma in total prostatectomy specimens. Br. J Urol 1992; In press.
  • Tribukait B, Esposti PL, Ronstrom L. Quantitative and qualitative aspects of flow DNA measurements related to the cytologic grade in prostatic carcinoma. Anal Quant 1983; 5: 107–111.
  • UICC. TNM classification of malignant tumours. 3rd ed. Geneva 1978. (revised 1982): 118–121.
  • Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function, anatomical and pathological considerations. Prostate 1983; 4: 473.
  • Wirth MP, Müller HH, Manseck A, Müller J, Frohmüller HGW. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy. Eur Urol 1991; 20: 248–252.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.